Obstructive sleep apnea and hypertension: An update

Hypertension

Volumn 63, Issue 2, 2014, Pages 203-209

  Konecny, Tomas ^a,b   Kara, Tomas ^a,b   Somers, Virend K ^a  

^a MAYO CLINIC   (United States)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR;

APNEA HYPOPNEA INDEX; ARTICLE; CARDIOVASCULAR RISK; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; CIRCADIAN RHYTHM; DYSLIPIDEMIA; ELEVATED BLOOD PRESSURE; FIBROSING ALVEOLITIS; HEMODYNAMICS; HUMAN; HYPERCAPNIA; HYPERTENSION; HYPOXEMIA; IMPAIRED GLUCOSE TOLERANCE; KIDNEY DENERVATION; METABOLIC SYNDROME X; OBESITY; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REM SLEEP; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SLEEP DISORDERED BREATHING; SPINAL CORD INJURY;

EID: 84892921839     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.00613     Document Type: Article

References (73)

1. Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LK, Amaro AC, Amodeo C, Bortolotto LA, Krieger EM, Bradley TD, Lorenzi-Filho G. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011;58:811-817.
2. Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B, Skatrud J. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med. 1997;157:1746-1752.
3. Haas DC, Foster GL, Nieto FJ, Redline S, Resnick HE, Robbins JA, Young T, Pickering TG. Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation. 2005;111:614-621.
4. Cano-Pumarega I, Dur?-Cantolla J, Aizpuru F, Miranda-Serrano E, Rubio R, Mart?ez-Null C, de Miguel J, Egea C, Cancelo L, Alvarez A, Fern?dez-Bola?s M, Barb?F. Obstructive sleep apnea and systemic hypertension: longitudinal study in the general population: the Vitoria Sleep Cohort. Am J Respir Crit Care Med. 2011;184:1299-1304.
5. Marin JM, Agusti A, Villar I, Forner M, Nieto D, Carrizo SJ, Barb?F, Vicente E, Wei Y, Nieto FJ, Jelic S. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA. 2012;307:2169-2176.
6. Sforza E, Chouchou F, Collet P, Pichot V, Barthy JC, Roche F. Sex differences in obstructive sleep apnoea in an elderly French population. Eur Respir J. 2011;37:1137-1143.
7. Roche F, P?in JL, Achour-Crawford E, Tamisier R, Pichot V, Celle S, Maudoux D, Chouchou F, Ntougou-Assoumou HG, L?y P, Barthy JC; PROOF Study Group. At 68 years, unrecognised sleep apnoea is associated with elevated ambulatory blood pressure. Eur Respir J. 2012;40:649-656.
8. Brostr? A, Sunnergren O, Johansson P, Svensson E, Ulander M, Nilsen P, Svanborg E. Symptom profile of undiagnosed obstructive sleep apnoea in hypertensive outpatients in primary care: a structural equation model analysis. Qual Prim Care. 2012;20:287-298.
9. LaVela SL, Burns SP, Goldstein B, Miskevics S, Smith B, Weaver FM. Dysfunctional sleep in persons with spinal cord injuries and disorders. Spinal Cord. 2012;50:682-685.
10. Cereda CW, Tamisier R, Manconi M, Andreotti J, Frangi J, Pifferini V, Bassetti CL. Endothelial dysfunction and arterial stiffness in ischemic stroke: the role of sleep-disordered breathing. Stroke. 2013;44:1175-1178.
11. Bixler EO, Vgontzas AN, Lin HM, Liao D, Calhoun S, Fedok F, Vlasic V, Graff G. Blood pressure associated with sleep-disordered breathing in a population sample of children. Hypertension. 2008;52:841-846.
12. Archbold KH, Vasquez MM, Goodwin JL, Quan SF. Effects of sleep patterns and obesity on increases in blood pressure in a 5-year period: report from the Tucson Children's Assessment of Sleep Apnea Study. J Pediatr. 2012;161:26-30.
13. Endeshaw YW, White WB, Kutner M, Ouslander JG, Bliwise DL. Sleep-disordered breathing and 24-hour blood pressure pattern among older adults. J Gerontol A Biol Sci Med Sci. 2009;64:280-285.
14. Waeber B, Mourad JJ, O'Brien E. Nighttime blood pressure: a target for therapy? Curr Hypertens Rep. 2010;12:474-479.
15. von K?el R, Natarajan L, Ancoli-Israel S, Mills PJ, Loredo JS, Dimsdale JE. Day/night rhythm of hemostatic factors in obstructive sleep apnea. Sleep. 2010;33:371-377.
16. Sasaki N, Ozono R, Yamauchi R, Teramen K, Edahiro Y, Ishii K, Seto A, Kihara Y. The relationship between morning hypertension and sleep quality in patients with obstructive sleep apnea syndrome. Clin Exp Hypertens. 2013;35:250-256.
17. Horne RS, Yang JS, Walter LM, Richardson HL, O'Driscoll DM, Foster AM, Wong S, Ng ML, Bashir F, Patterson R, Jolley D, Walker AM, Anderson V, Davey MJ, Nixon GM. Nocturnal dipping is preserved in children with sleep disordered breathing regardless of its severity. Pediatr Pulmonol. 2013;48:1127-1134.
18. Nisbet LC, Yiallourou SR, Biggs SN, Nixon GM, Davey MJ, Trinder JA, Walter LM, Horne RS. Preschool children with obstructive sleep apnea: the beginnings of elevated blood pressure? Sleep. 2013;36:1219-1226.
19. Konecny T, Somers VK. Chapter 112: Sleep apnea. In: RobertsonD, Biaggioni I, Burnstock G, Low PA, Paton JFR, eds. Primer on the Autonomic Nervous System. 3rd ed. San Diego, CA: Elsevier; 2012.
20. Parati G, Lombardi C, Hedner J, Bonsignore MR, Grote L, Tkacova R, Levy P, Riha R, Bassetti C, Narkiewicz K, Mancia G, McNicholas WT. Position paper on the management of patients with obstructive sleep apnea and hypertension: Joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological Research) ACTION B26 on obstructive sleep apnea. J Hypertens. 2012;30:633-646.
21. Freet CS, Stoner JF, Tang X. Baroreflex and chemoreflex controls of sympathetic activity following intermittent hypoxia. Auton Neurosci. 2013;174:8-14.
22. Leung RS. Sleep-disordered breathing: autonomic mechanisms and arrhythmias. Prog Cardiovasc Dis. 2009;51:324-338.
23. Pinto P, B?bara C, Montserrat JM, Patarr? RS, Guarino MP, Carmo MM, Macedo MP, Martinho C, Dias R, Gomes MJ. Effects of CPAP on nitrate and norepinephrine levels in severe and mild-moderate sleep apnea. BMC Pulm Med. 2013;13:13.
24. Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, Wirth K, B?m M. Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension. 2012;60:172-178.
25. Testelmans D, Tamisier R, Barone-Rochette G, Baguet JP, Roux-Lombard P, P?in JL, L?y P. Profile of circulating cytokines: impact of OSA, obesity and acute cardiovascular events. Cytokine. 2013;62:210-216.
26. Totoson P, Fhayli W, Faury G, Korichneva I, Cachot S, Baldazza M, Ribuot C, P?in JL, L?y P, Joyeux-Faure M. Atorvastatin protects against deleterious cardiovascular consequences induced by chronic intermittent hypoxia. Exp Biol Med (Maywood). 2013;238:223-232.
27. Rizzi CF, Cintra F, Mello-Fujita L, Rios LF, Mendonca ET, Feres MC, Tufik S, Poyares D. Does obstructive sleep apnea impair the cardiopulmonary response to exercise? Sleep. 2013;36:547-553.
28. Mansukhani MP, Allison TG, Lopez-Jimenez F, Somers VK, Caples SM. Functional aerobic capacity in patients with sleep-disordered breathing. Am J Cardiol. 2013;111:1650-1654.
29. Patel HM, Mast JL, Sinoway LI, Muller MD. Effect of healthy aging on renal vascular responses to local cooling and apnea. J Appl Physiol (1985). 2013;115:90-96.
30. Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL, Cofield SS, Harding SM, Calhoun DA. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest. 2007;131:453-459.
31. Pimenta E, Stowasser M, Gordon RD, Harding SM, Batlouni M, Zhang B, Oparil S, Calhoun DA. Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism. Chest. 2013;143:978-983.
32. Friedman O, Bradley TD, Logan AG. Influence of lower body positive pressure on upper airway cross-sectional area in drug-resistant hypertension. Hypertension. 2013;61:240-245.
33. Fernandez-Mendoza J, Vgontzas AN, Liao D, Shaffer ML, Vela-Bueno A, Basta M, Bixler EO. Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort. Hypertension. 2012;60:929-935.
34. Sunbul M, Kanar BG, Durmus E, Kivrak T, Sari I. Acute sleep deprivation is associated with increased arterial stiffness in healthy young adults. Sleep Breath. 2013 Jul 14 [Epub ahead of print].
35. Dettoni JL, Consolim-Colombo FM, Drager LF, Rubira MC, Souza SB, Irigoyen MC, Mostarda C, Borile S, Krieger EM, Moreno H Jr, Lorenzi-Filho G. Cardiovascular effects of partial sleep deprivation in healthy volunteers. J Appl Physiol (1985). 2012;113:232-236.
36. Carev M, Karanovi? N, Bagatin J, Matuli? NB, Pecoti? R, Vali? M, Marinovi?-Terzi? I, Karanovi? S, Dogas Z. Blood pressure dipping and salivary cortisol as markers of fatigue and sleep deprivation in staff anesthesiologists. Coll Antropol. 2011;35(suppl 1):133-138.
37. Buxton OM, Pavlova M, Reid EW, Wang W, Simonson DC, Adler GK. Sleep restriction for 1 week reduces insulin sensitivity in healthy men. Diabetes. 2010;59:2126-2133.
38. Latshang TD, Nussbaumer-Ochsner Y, Henn RM, Ulrich S, Lo Cascio CM, Ledergerber B, Kohler M, Bloch KE. Effect of acetazolamide and autoCPAP therapy on breathing disturbances among patients with obstructive sleep apnea syndrome who travel to altitude: a randomized controlled trial. JAMA. 2012;308:2390-2398.
39. Jimenez Caballero PE, Coloma Navarro R, Segura Martn T, Ayo Martn O. Cerebral hemodynamic changes at basilar artery in patients with obstructive sleep apnea syndrome. A case-control study. Acta Neurol Scand. 2013 Jun 13 [Epub ahead of print].
40. Jim?ez Caballero PE, Coloma Navarro R, Ayo Mart? O, Segura Mart? T. Cerebral hemodynamic changes in obstructive sleep apnea syndrome after continuous positive airway pressure treatment. Sleep Breath. 2013;17:1103-1108.
41. Knight WD, Little JT, Carreno FR, Toney GM, Mifflin SW, Cunningham JT. Chronic intermittent hypoxia increases blood pressure and expression of FosB/DeltaFosB in central autonomic regions. Am J Physiol Regul Integr Comp Physiol. 2011;301:R131-R139.
42. Cunningham JT, Knight WD, Mifflin SW, Nestler EJ. An Essential role for DeltaFosB in the median preoptic nucleus in the sustained hypertensive effects of chronic intermittent hypoxia. Hypertension. 2012;60:179-187.
43. Capone C, Faraco G, Coleman C, Young CN, Pickel VM, Anrather J, Davisson RL, Iadecola C. Endothelin 1-dependent neurovascular dysfunction in chronic intermittent hypoxia. Hypertension. 2012;60:106-113.
44. Kolilekas L, Manali E, Vlami KA, Lyberopoulos P, Triantafillidou C, Kagouridis K, Baou K, Gyftopoulos S, Vougas KN, Karakatsani A, Alchanatis M, Papiris S. Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis. J Clin Sleep Med. 2013;9:593-601.
45. Jilwan FN, Escourrou P, Garcia G, Ja? X, Humbert M, Roisman G. High occurrence of hypoxemic sleep respiratory disorders in precapillary pulmonary hypertension and mechanisms. Chest. 2013;143:47-55.
46. Colish J, Walker JR, Elmayergi N, Almutairi S, Alharbi F, Lytwyn M, Francis A, Bohonis S, Zeglinski M, Kirkpatrick ID, Sharma S, Jassal DS. Obstructive sleep apnea: effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI. Chest. 2012;141:674-681.
47. Konecny T, Kuniyoshi FH, Orban M, Pressman GS, Kara T, Gami A, Caples SM, Lopez-Jimenez F, Somers VK. Under-diagnosis of sleep apnea in patients after acute myocardial infarction. J Am Coll Cardiol. 2010;56:742-743.
48. Konecny T, Brady PA, Orban M, Lin G, Pressman GS, Lehar F, Tomas K, Gersh BJ, Tajik AJ, Ommen SR, Somers VK. Interactions between sleep disordered breathing and atrial fibrillation in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2010;105:1597-1602.
49. Clarenbach CF, Camen G, Sievi NA, Wyss C, Stradling JR, Kohler M. Effect of simulated obstructive hypopnea and apnea on thoracic aortic wall transmural pressures. J Appl Physiol (1985). 2013;115:613-617.
50. Kohler M, Craig S, Pepperell JC, Nicoll D, Bratton DJ, Nunn AJ, Leeson P, Stradling JR. CPAP improves endothelial function in patients with minimally symptomatic OSA: results from a subset study of the MOSAIC trial. Chest. 2013;144:896-902.
51. Akinnusi ME, Laporta R, El-Solh AA. Lectin-like oxidized low-density lipoprotein receptor-1 modulates endothelial apoptosis in obstructive sleep apnea. Chest. 2011;140:1503-1510.
52. Ghias M, Scherlag BJ, Lu Z, Niu G, Moers A, Jackman WM, Lazzara R, Po SS. The role of ganglionated plexi in apnea-related atrial fibrillation. J Am Coll Cardiol. 2009;54:2075-2083.
53. Lu Z, Nie L, He B, Yu L, Salim M, Huang B, Cui B, He W, Wu W, Jiang H. Increase in vulnerability of atrial fibrillation in an acute intermittent hypoxia model: importance of autonomic imbalance. Auton Neurosci. 2013;177:148-153.
54. Phillips CL, Yee BJ, Marshall NS, Liu PY, Sullivan DR, Grunstein RR. Continuous positive airway pressure reduces postprandial lipidemia in obstructive sleep apnea: a randomized, placebo-controlled crossover trial. Am J Respir Crit Care Med. 2011;184:355-361.
55. Tuomilehto H, Gylling H, Peltonen M, Martikainen T, Sahlman J, Kokkarinen J, Randell J, Tukiainen H, Vanninen E, Partinen M, Tuomilehto J, Uusitupa M, Sepp?J; Kuopio Sleep Apnea Group. Sustained improvement in mild obstructive sleep apnea after a diet-and physical activity-based lifestyle intervention: postinterventional follow-up. Am J Clin Nutr. 2010;92:688-696.
56. Lindberg E, Theorell-Hagl? J, Svensson M, Gislason T, Berne C, Janson C. Sleep apnea and glucose metabolism: a long-term follow-up in a community-based sample. Chest. 2012;142:935-942.
57. Witkowski A, Prejbisz A, Florczak E, K?dziela J, ?liwi?ski P, Biele? P, Micha?owska I, Kabat M, Warcho? E, Januszewicz M, Narkiewicz K, Somers VK, Sobotka PA, Januszewicz A. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension. 2011;58:559-565.
58. Barb?F, Dur?-Cantolla J, S?chez-de-la-Torre M, et al; Spanish Sleep And Breathing Network. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;307:2161-2168.
59. Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007;50:417-423.
60. Montesi SB, Edwards BA, Malhotra A, Bakker JP. The effect of continuous positive airway pressure treatment on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Clin Sleep Med. 2012;8:587-596.
61. Yorgun H, Kabakci G, Canpolat U, Kirmizigul E, Sahiner L, Ates AH, Sendur MA, Kaya EB, Demir AU, Aytemir K, Tokgozoglu L, Oto A. Predictors of blood pressure reduction with nocturnal continuous positive airway pressure therapy in patients with obstructive sleep apnea and prehypertension. Angiology. 2013 Feb 20 [Epub ahead of print].
62. Myhill PC, Davis WA, Peters KE, Chubb SA, Hillman D, Davis TM. Effect of continuous positive airway pressure therapy on cardiovascular risk factors in patients with type 2 diabetes and obstructive sleep apnea. J Clin Endocrinol Metab. 2012;97:4212-4218.
63. Drager LF, Pedrosa RP, Diniz PM, Diegues-Silva L, Marcondes B, Couto RB, Giorgi DM, Krieger EM, Lorenzi-Filho G. The effects of continuous positive airway pressure on prehypertension and masked hypertension in men with severe obstructive sleep apnea. Hypertension. 2011;57:549-555.
64. Zhao Q, Liu ZH, Luo Q, Zhao ZH, Zhang HL, Wang Y. Effects of continuous positive airway pressure on blood pressure and daytime sleepiness in obstructive sleep apnea patients with coronary heart diseases under optimal medications. Sleep Breath. 2012;16:341-347.
65. Sharma SK, Agrawal S, Damodaran D, Sreenivas V, Kadhiravan T, Lakshmy R, Jagia P, Kumar A. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med. 2011;365:2277-2286.
66. Li W, Xiao L, Hu J. The comparison of CPAP and oral appliances in treatment of patients with OSA: a systematic review and meta-analysis. Respir Care. 2013;58:1184-1195.
67. Iftikhar IH, Hays ER, Iverson MA, Magalang UJ, Maas AK. Effect of oral appliances on blood pressure in obstructive sleep apnea: a systematic review and meta-analysis. J Clin Sleep Med. 2013;9:165-174.
68. Phillips CL, Grunstein RR, Darendeliler MA, Mihailidou AS, Srinivasan VK, Yee BJ, Marks GB, Cistulli PA. Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med. 2013;187:879-887.
69. Hady HR, Dadan J, Go?aszewski P. 100 obese patients after laparoscopic adjustable gastric banding-the influence on BMI, gherlin and insulin concentration, parameters of lipid balance and co-morbidities. Adv Med Sci. 2012;57:58-64.
70. Woodman G, Cywes R, Billy H, Montgomery K, Cornell C, Okerson T; APEX Study Group. Effect of adjustable gastric banding on changes in gastroesophageal reflux disease (GERD) and quality of life. Curr Med Res Opin. 2012;28:581-589.
71. Dixon JB, Schachter LM, O'Brien PE, Jones K, Grima M, Lambert G, Brown W, Bailey M, Naughton MT. Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;308:1142-1149.
72. Bejan-Angoulvant T, Baguet JP, Erpeldinger S, Boivin JM, Mercier A, Leftheriotis G, Gagnol JP, Fauvel JP, Giraud C, Bricca G, Gueyffier F. The IDEAL study: Towards personalized drug treatment of hypertension. Therapie. 2012;67:195-204.
73. Bravata DM, Ferguson J, Miech EJ, et al. Diagnosis and treatment of sleep apnea in patients' homes: the rationale and methods of the " GoToSleep" randomized-controlled trial. J Clin Sleep Med. 2012;8:27-35.